OTL38

· On Target Laboratories, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OTL38, covering 2022-02-04 to 2023-03-24. Get the full timeline:

Most recent: Clinical Trial Update: OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules [Phase 2]